FindTrial
Sign In

Diabetic maculopathy.

Macular Choroidal thickness as a novel indicator to discern between non-ischemic and ischemic diabetic maculopathy.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/03/012733
Enrollment
250
Registered
2018-03-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NIL: NIL

Sponsors

Giridhar Eye Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with treatment naive diabetic retinopathy who underwent DFA & EDI-OCT Imaging.

Exclusion criteria

Exclusion criteria: (a) Diabetic patients who have received any ocular intervention for retinopathy such as laser photocoagulation and intravitreal injections (b) previous ocular surgery (other than cataract) (c) presence of any other posterior segment disorders

Design outcomes

Primary

MeasureTime frame
To evaluate the changes in macular choroidal thickness in eyes with two forms of diabetic maculopathuy - ischemic and non-ischemic with diabetic patients without retinopathy changes as control.Timepoint: 3 months—

Secondary

MeasureTime frame
Creation of database for better treatment options.Timepoint: 3 Months—

Countries

India

Contacts

Public ContactDr Jay Sheth

Giridhar Eye Institute

drjay009@gmail.com9961167200

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026